CTOs on the Move

Invitrogen Corporation

www.invitrogen.com

 
Life Technologies Corp., (NASDAQ: LIFE) www.lifetechnologies.com - On November 21, 2008, Invitrogen Corporation and Applied Biosystems Inc announced the completion of their merger transaction. Effective November 24, 2008, the two companies merged to form a new company under the name, Life Technologies Corporation
  • Number of Employees: 1K-5K
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Sentry BioPharma Services

Sentry BioPharma Services is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Southern Piedmont Community Care Plan

Southern Piedmont Community Care Plan is a Concord, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CareFinders Total Care

Care Finders Total Care provides the highest level of home care and personalized service to patients of all ages including children, adults and the elderly. Care Finders Total Care provides reliable Certified Home Health Aides who will make sure that while they provide the care you need, your independence, dignity and religious customs are maintained, regardless of your disability or illness.

JSA Healthcare Corp

JSA Healthcare Corporation is a leading provider of high quality healthcare services. Our facilities include 34 primary care practices in the greater Tampa Bay and Orlando areas under the JSA Medical Group name.

RainTree Oncology Services

As the nation’s leading community oncology alliance, RainTree Oncology Services assists our member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices through. Creating a unique aggregated data compilation and analytic platform allowing RainTree members to develop and evaluate care pathways to improve patient care and outcomes while reducing costs to the health care system; and Developing commercial relationships accelerating innovative oncology treatments and payer arrangements while optimizing oncology patient care and advancing the science of oncology.